News from Crescent and our Investees
PathXL provide digital microscopy systems for Molecular Pathology Laboratory and Biobank.
BELFAST, NORTHERN IRELAND, 9 January 2013: Crescent Capital’s PathXL is proud to be involved with the Northern Ireland Biobank... Find Out More
PathXL investment clinches Deal of the Month
BELFAST, NORTHERN IRELAND, 2 January 2013: The seven-figure sum investment in medical technology company, PathXL, a Crescent Capital portfolio company, has been named... Find Out More
Seven figure investment announced by Belfast software pioneer PathXL
Digital pathology company to expand cancer research & diagnosis support products BELFAST, NORTHERN IRELAND, 13 December 2012: PathXL, a... Find Out MoreFrost & Sullivan Honours PathXL with Enabling Technology Award
PathXL Recognised for its Pioneering Digital Pathology Solutions LONDON, April 19, 2012 /PRNewswire/ — Based on its recent analysis of web-based software... Find Out MoreSpeechStorm Launches Mobile Customer Experience Managemetn Applications at Mobile World Congress
Mobile World Congress, Barcelona, 27 February, 2012 – Leading Customer Experience Management (CEM) application company, SpeechStorm, will be launching... Find Out More